Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2002 | 06-2002 | |
| Operating Expenses | 171 | 131 |
| Operating Income | -171 | -131 |
| Interest Expense | 2 | 2 |
| Other Income | 1 | 1 |
| Pre-tax Income | -172 | -132 |
| Net Income Continuous | -172 | -132 |
| Net Income | $-172 | $-132 |
| EPS Basic Total Ops | -0.02 | -0.01 |
| EPS Basic Continuous Ops | -0.02 | -0.01 |
| EPS Diluted Total Ops | -0.02 | -0.01 |
| EPS Diluted Continuous Ops | -0.02 | -0.01 |
| EBITDA(a) | $-170 | $-131 |